首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1472020

獸用輔料市場- 依產品類型（黏合劑、崩解劑、乳化劑、填充劑）、配方（口服、注射）、動物類型（牲畜、伴侶）、應用（藥物配方、飼料添加劑、生物製品）、全球預測2024 - 2032

Veterinary Excipients Market - By Product Type (Binders, Disintegrants, Emulsifiers, Fillers), Formulation (Oral, Injectable), Animal Type (Livestock, Companion), Application (Drug Formulation, Feed Additives, Biologics), Global Forecast 2024 - 2032

出版日期: 2024年02月29日 | 出版商:

Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於動物藥品和保健產品的需求不斷增加，預計 2024 年至 2032 年間，獸用輔料市場規模的複合年成長率將超過 3.7%。獸醫學和生物技術的不斷進步促進了新藥物配方的開發，對高品質賦形劑的需求不斷增加，以提高藥物的穩定性、溶解度和生物利用度。

寵物主人對預防保健重要性和各種獸藥供應的認知不斷提高，增加了對片劑、膠囊和溶液等劑型配方中賦形劑的需求。此外，新型藥物輸送技術的出現以及對動物個人化醫療的強烈關注也增加了對具有特定功能的創新產品的需求。例如，2024 年 2 月，率先為狗提供長壽藥物的生物技術公司 Loyal 宣布了其藥物 LOY-002 的關鍵臨床試驗 STAY 研究中第一隻狗的劑量。

獸用輔料產業依產品種類、劑型、動物種類、應用、地區等分類。

根據產品類型，填充劑和稀釋劑領域的市場規模在預測期內的複合年成長率將達到 3.8%。這可以歸因於它們透過改善劑型的物理特性（例如片劑可壓縮性和粉末流動性）來提高生產效率，從而在藥物配方中提供越來越多的幫助。此外，它們還具有配方多功能性以及與多種活性藥物成分 (API) 的兼容性，使其成為獸藥開發中不可或缺的組成部分。

在配方方面，由於注射劑領域的獸用輔料在動物用藥中發揮關鍵作用，預計 2024 年至 2032 年期間獸用輔料市場將出現強勁成長。它們具有快速起效、精確的劑量傳遞和改善的患者依從性，成為獸醫保健專業人員的首選。隨著注射藥物的需求持續成長，同時也需要賦形劑來增強製劑的穩定性、溶解度和安全性。注射製劑中使用的賦形劑還具有緩衝、張力調節和黏度調節等關鍵功能，以確保獸藥的功效和安全性。

亞太地區獸藥輔料產業預計在 2024 年至 2032 年期間將實現 4.3% 的成長率。伴侶動物和牲畜數量的增加推動了對高品質輔料的需求，以支持藥物配方的開發。此外，中國、印度和東南亞國家等新興經濟體動物保健產業的快速擴張為輔料製造商和供應商帶來了巨大的機會。旨在促進動物健康和福利的政府支持舉措，加上獸醫和生物技術的進步，將進一步刺激該區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 人畜共通傳染病數量增加
  - 人們對動物健康的認知不斷提高
  - 都市化和畜牧業產業化不斷發展
  - 寵物擁有量的增加推動獸醫護理需求
  - 政府對獸醫護理的支持不斷增加
  - 不斷成長的研發和程序進步
- 產業陷阱與挑戰
  - 獸藥成本高
  - 發展中經濟體缺乏獲得優質獸醫護理的機會
成長潛力分析
監管環境
母公司市場展望
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀錶板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

主要趨勢
黏合劑
崩解劑
黏度劑
填充劑和稀釋劑
調味劑
潤滑劑和助流劑
乳化劑
防腐劑
其他產品類型

第 6 章：市場估計與預測：按配方分類，2018 年 - 2032 年

主要趨勢
口服
可注射
專題
其他配方

第 7 章：市場估計與預測：按動物類型，2018 - 2032

主要趨勢
畜牧動物
伴侶動物

第 8 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
藥物製劑
飼料添加劑
生物製劑

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 10 章：公司簡介

Alchemy Impex.
Azelis Group
BASF SE
Clariant
Colorcon
Croda International Plc
Gattefosse Group
IOI Oleo GmbH
JRS Pharma
Lipoid GmbH
Seppic
Synergy API

簡介目錄

Product Code: 8323

Veterinary Excipients Market size is estimated to record over 3.7% CAGR between 2024 and 2032, owing to the increasing need for pharmaceuticals and healthcare products for animals. Rising advancements in veterinary medicine and biotechnology have led to the development of new pharmaceutical formulations, creating increasing demand for high-quality excipients to enhance drug stability, solubility, and bioavailability.

The growing awareness among pet owners regarding the importance of preventive care and the availability of a wide range of veterinary pharmaceuticals has increased the demand for excipients in the formulation of dosage forms, such as tablets, capsules, and solutions. Additionally, the emergence of novel drug delivery technologies and the strong focus on personalized medicine for animals are contributing to the demand for innovative product with specific functionalities. For instance, in February 2024, Loyal, a biotech company that pioneered longevity drugs for dogs, announced the dosage of first dog in its STAY study, the pivotal clinical trial for its drug LOY-002.

The veterinary excipients industry is classified into product type, formulation, animal type, application, and region.

Based on product type, the market size from the fillers and diluents segment will witness 3.8% CAGR in the forecast period. This can be ascribed to their rising assistance in pharmaceutical formulations by improving the physical properties of dosage forms, such as tablet compressibility and powder flowability for enhancing manufacturing efficiency. Moreover, they offer formulation versatility and compatibility with a wide range of active pharmaceutical ingredients (APIs), making them indispensable components in veterinary drug development.

In terms of formulation, the veterinary excipients market from the injectable segment is projected to register strong growth between 2024 and 2032, due to their pivotal role in the administration of pharmaceuticals to animals. They offer rapid onset of action, precise dosage delivery, and improved patient compliance, emerging as preferred choice for veterinary healthcare professionals. As the demand for injectable pharmaceuticals continues to rise, there is a parallel need for excipients to enhance formulation stability, solubility, and safety. Excipients used in injectable formulations also serve critical functions like buffering, tonicity adjustment, and viscosity modification for ensuring the efficacy and safety of veterinary drugs.

Asia Pacific veterinary excipients industry is slated to record 4.3% growth rate during 2024-2032. The rising population of companion animals and livestock is fueling the need for high-quality excipients to support pharmaceutical formulation development. Furthermore, the rapid expansion of the animal health industry in emerging economies, such as China, India, and Southeast Asian countries is presenting significant opportunities for excipient manufacturers and suppliers. Supportive government initiatives aimed at promoting animal health and welfare, coupled with advancements in veterinary medicine and biotechnology, will further stimulate the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data validation
1.4 Forecast parameters
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increase in the number of zoonotic diseases
  - 3.2.1.2 Rising awareness about animal health
  - 3.2.1.3 Growing urbanization and industrialization of livestock farming
  - 3.2.1.4 Increasing pet ownership propels veterinary care demand
  - 3.2.1.5 Growing government support on veterinary care
  - 3.2.1.6 Rising R&D and procedural advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of veterinary medicines
  - 3.2.2.2 Lack of access to quality veterinary care in developing economies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Parent market outlook
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Binders
5.3 Disintegrants
5.4 Viscosity agents
5.5 Fillers and diluents
5.6 Flavoring agents
5.7 Lubricants and glidants
5.8 Emulsifiers
5.9 Preservatives
5.10 Other product types

Chapter 6 Market Estimates and Forecast, By Formulation, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Oral
6.3 Injectable
6.4 Topical
6.5 Other formulations

Chapter 7 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Livestock animals
7.3 Companion animals

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Drug formulation
8.3 Feed additives
8.4 Biologics

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa